Mk-801 does not enhance dopaminergic cell survival in embryonic nigral grafts

NeuroReport

Volumn 9, Issue 7, 1998, Pages 1313-1316

  Schierle, Gabriele S ^a   Karlsson, Jenny ^a   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Dopamine; Excitotoxicity; Intracerebral transplantation; MK 801; Parkinson's disease

Indexed keywords

DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; MESENCEPHALON; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT;

EID: 0032507628     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199805110-00011     Document Type: Article

References (27)

1. Brundin P, Duan W-M and Sauer H. Functional effects of mesencephalic dopamine neurones and adrenal chromaffin cells grafted to the rodent striatum. In: Dunnett SB and Björklund A, eds. Functional Neural Transplantation. New York: Raven Press, 1994: 9-46.
2. Annett LE. In: Dunnett SB and Björklund A, eds. Functional studies of neural grafts in parkinsonian primates. Functional Neural Transplantation. New York: Raven Press, 1994: 71-102.
3. Lindvall O. NeuroReport 8, iii-x (1997).
4. Duan W-M, Widner H and Brundin P. Exp Brain Res 104, 227-242 (1995).
5. Mayer E, Dunnett SB and Fawcett JV. Neuroscience 56, 389-398 (1993).
6. Takayama H, Ray J, Raymon HK et al. Nature Med 1, 53-58 (1995).
7. Rosenblad C, Martinez-Serrano A and Björklund A. Neuroscience 75, 979-985 (1996).
8. Sinclair SR, Svendsen CN, Torres EM et al. NeuroReport 7, 2547-2552 (1996).
9. Frodl EM, Nakao N and Brundin P. NeuroReport 5, 2393-2396 (1994).
10. Nakao N, Frodl EM, Duan WM et al. Proc Natl Acad Sci USA 91, 12408-12412 (1994).
11. Fridovich I. Adv Enzymol 58, 61-97 (1986).
12. Nakao N, Frodl EM, Widner H et al. Nature Med 1, 226-231 (1995).
13. Okiyama K, Smith DH, Gennarelli TA et al. J Neurochem 64, 802-809 (1995).
14. Finger S and Dunnett SB. Exp Neurol 104, 1-9 (1989).
15. Frodl EM, Nakao N and Brundin P. Brain Res Bulletin 39, 341-347 (1996).
16. Ungerstedt U and Arbuthnott GW. Brain Res 24, 485-493 (1970).
17. Schmidt RH, Björklund A, Stenevi U et al. Acta Physiol Scand Suppl 522, 19-28 (1983).
18. Abercrombie M. Anat Rec 94, 239-247 (1946).
19. Sauer H, Brundin P. Rest Neurol Neurosci 2, 123-135 (1991).
20. Atabay C, Cagnoli CM, Kharlamov E et al. J Neurosci Res 43, 465-475 (1996).
21. Hyman C, Hofer M, Barde Y-A et al. Nature 350, 230-232 (1991).
22. Hyman C, Juhasz M, Jackson C et al. J Neurosci 14, 335-347 (1994).
23. Sauer H, Fischer W, Nikkhah G et al. Brain Res 626, 37-44 (1993).
24. Yurek DM, Lu W, Hipkens S et al. Exp Neurol 137, 105-118 (1996).
25. Hague NS, Hlavin ML, Fawcett JW et al. Brain Res 712, 45-52 (1996).
26. Ball EF, Shaw PJ, Ince PG et al. Brain Res 658, 209-218 (1994).
27. Coyle JT and Puttfarcken P. Science 262, 689-694 (1993).